Literature DB >> 11782570

Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus.

Marie-Agnès Giroux1, Marie-Pierre Audrezet, Jean-Philippe Metges, Patrick Lozac'h, Alain Volant, Jean-Baptiste Nousbaum, Jean-Paul Labat, Hervé Gouérou, Claude Ferec, Michel Robaszkiewicz.   

Abstract

Loss of heterozygosity (LOH) on chromosome 9 and p16 (MTS1/CDKN2) gene mutations have been reported in various human cancers. The present study aimed to determine the prevalence of LOH in 100 oesophageal squamous cell carcinomas (OSCCs) by typing microsatellite loci and mutations of the p16 gene. The methods used included denaturing gradient gel electrophoresis (DGGE) and DNA sequencing of exon 2. LOH was found in 14.7% of the OSCC cases. Six gene alterations were identified in exon 2. They consisted of three deletions and the same polymorphism in three samples. The relatively low rate of p16 mutation compared with the frequency of LOH suggests the possible involvement of another tumour suppressor gene located on chromosome 9 in oesophageal carcinogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 11782570     DOI: 10.1097/00042737-200201000-00004

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

1.  Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance.

Authors:  Xiu-Sheng He; Ying-Hui Rong; Qi Su; Qiao Luo; Dong-Mei He; Yan-Lan Li; Yan Chen
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

2.  p16 mutation spectrum in the premalignant condition Barrett's esophagus.

Authors:  Thomas G Paulson; Patricia C Galipeau; Lianjun Xu; Heather D Kissel; Xiaohong Li; Patricia L Blount; Carissa A Sanchez; Robert D Odze; Brian J Reid
Journal:  PLoS One       Date:  2008-11-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.